Search - tctmd.com

Displaying 21 - 40 of 182

Sort: Relevancy | Date

News Daily News

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

L.A. McKeown

February 21, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Daily News

Sham Procedures in CV Research: What’s Sacrificed for Science?

Caitlin E. Cox

October 23, 2023

News Daily News

Small Study Hints at Mechanism for COVID-Related MI and Stroke

L.A. McKeown

October 02, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2023

Shelley Wood

May 31, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News EAS 2023

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

Michael O'Riordan

May 26, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

Advertisement

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

November 2023 News Roundup

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Sham Procedures in CV Research: What’s Sacrificed for Science?

Small Study Hints at Mechanism for COVID-Related MI and Stroke

September 2023 News Roundup

TCTMD’s Michael O’Riordan Wins Digital Health Award

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

LDL Control Remains Poor in CAD Patients: NHANES

Method to Overcome CAC Score Variability Hones Risk Stratification

TCTMD’s Top 10 Most Popular Stories for May 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content